Why Investors Should Stick to Skye Bioscience Inc (NASDAQ: SKYE) Stock in 2025
In the last trading session, 1.74 million Skye Bioscience Inc (NASDAQ:SKYE) shares changed hands as the company’s beta touched 1.96. With the company’s per share
In the last trading session, 1.74 million Skye Bioscience Inc (NASDAQ:SKYE) shares changed hands as the company’s beta touched 1.96. With the company’s per share
In last trading session, Skye Bioscience Inc (NASDAQ:SKYE) saw 2.2 million shares changing hands with its beta currently measuring 1.78. Company’s recent per share price
Skye Bioscience Inc (NASDAQ:SKYE) has a beta value of 1.67 and has seen 13.62 million shares traded in the last trading session. The company, currently
During the last session, Skye Bioscience Inc (NASDAQ:SKYE)’s traded shares were 99947.0, with the beta value of the company hitting 1.67. At the end of
In last trading session, Skye Bioscience Inc (NASDAQ:SKYE) saw 0.34 million shares changing hands with its beta currently measuring 1.66. Company’s recent per share price
Skye Bioscience Inc (NASDAQ:SKYE)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 1.73. At the close of
© 2024, Powered by Smart TechOne